Delivery Order SPE2DB22D1041-SPE2DB24FUDS6
Award Date
9/11/24
Potential Completion Date
9/12/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,842.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this contract, which does not have a set-aside designation. As a key supplier to various federal...
This federal contract award, valued at $13,436.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, and has a firm fixed price pricing type with a completion date of March 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $5,980.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,161.28 firm-fixed-price delivery order is for the supply of 4565265781 ! ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a performance period ending on July 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by various...
This federal contract award, valued at $3,840.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has a period of performance through May 7, 2025 and is a firm fixed-price contract. This contract is not set-aside. As a large pharmaceutical supplier, AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,979.60, is a delivery order contract for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,723.53, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with a completion date of January 24, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,828.53, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of November 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,342.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,321,148 units of the pharmaceutical product ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,126.39 delivery order is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This award is part of Amerisourcebergen's broader indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military...